Download the Free Unbound MEDLINE PubMed App to your smartphone or tablet.
Available for iPhone, iPad, iPod touch, and Android:
Available for Mac and Windows Desktops and laptops:
- Breast Cancer Risk in Hyperprolactinemia Patients: A population-based cohort study and meta-analysis of the literature. [JOURNAL ARTICLE]
- Eur J Endocrinol 2015 May 26.
- Radiotherapy-induced Hypopituitarism in Nasopharyngeal Carcinoma: the Tip of an Iceberg. [JOURNAL ARTICLE]
- Exp Clin Endocrinol Diabetes 2015 May 26.
- Clinical and Biochemical Characteristics of Polycystic Ovarian Syndrome among Women in Bangladesh. [Journal Article]
- Mymensingh Med J 2015 Apr; 24(2):310-8.
- Association between endometriosis and hyperprolactinemia in infertile women. [Journal Article]
- Iran J Reprod Med 2015 Mar; 13(3):155-60.
- Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia. [Journal Article]
- Iran J Reprod Med 2015 Feb; 13(2):93-100.
- Effects of GnRH analogue treatment on anterior pituitary hormones in children with central precocious puberty. [JOURNAL ARTICLE]
- J Pediatr Endocrinol Metab 2015 May 22.
- Hypothalamic prolactin regulation of luteinizing hormone secretion in the female rat. [JOURNAL ARTICLE]
- Endocrinology 2015 May 20.:en20151040.
- Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study. [JOURNAL ARTICLE]
- Psychoneuroendocrinology 2015 Apr 24.:130-140.
- The effects of bromocriptine on preventing postpartum flare in systemic lupus erythematosus patients from South china. [Journal Article]
- J Immunol Res 2015.:316965.
Objective.Prolactin plays an important role on the disease flare of postpartum SLE patients. 76 pregnant SLE patients were enrolled in this study to evaluate the efficacy of bromocriptine (an inhibitor of prolactin secretion) on preventing the postpartum disease relapse. Methods. Patients were randomly divided into the treatment group (bromocriptine, 2.5 mg oral, twice a day for 14 days after delivery) and the control group. All the patients were followed up for 12 months. Clinical features were recorded every 4 weeks. Serum prolactin and estradiol levels were measured at the second week and the second month after delivery. The endpoint of the study was disease relapse and defined when SLEDAI score increased by ≥3 points from the antenatal baseline.
Results.(1) Serum levels of prolactin and estradiol decreased significantly in bromocriptine treatment group at the second week (P < 0.001) and second month (P < 0.05) after delivery compared to control group. (2) The relapse rate of the treatment group was lower than the control group (χ (2) = 4.68, P = 0.0305).
Conclusions.Two weeks of oral bromocriptine treatment in postpartum SLE patients may relieve the disease from hyperprolactinemia and hyperestrogenemia and may be beneficial in preventing the patients from disease relapse.
- Delusion of pregnancy: a systematic review of 84 cases in the literature. [Journal Article, Review]
- Indian J Psychol Med 2015 Apr-Jun; 37(2):131-7.